Lipidomics in vascular health: current perspectives

References

• KolovouGDKolovouVMavrogeniSWe are ageingBiomed Res Int2014201480830725045704
   PubMed Web of Science ®Google Scholar
• VasiliadisIKolovouGMavrogeniSNairDRMikhailidisDPSudden cardiac death and diabetes mellitusJ Diabetes Complications201428457357924666923
   PubMed Web of Science ®Google Scholar
• AveryPBarzilaiNBenetosAAgeing, longevity, exceptional longevity and related genetic and non genetics markers: panel statementCurr Vasc Pharmacol201412565966124350929
   PubMed Web of Science ®Google Scholar
• Silvestre-RoigCde WintherMPWeberCDaemenMJLutgensESoehnleinOAtherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategiesCirc Res2014114121422624385514
   PubMed Web of Science ®Google Scholar
• JeromeWGYanceyPGThe role of microscopy in understanding atherosclerotic lysosomal lipid metabolismMicrosc Microanal200391546712597787
   PubMed Web of Science ®Google Scholar
• FahyESubramaniamSBrownHAA comprehensive classification system for lipidsJ Lipid Res200546583986115722563
   PubMed Web of Science ®Google Scholar
• HanXGrossRWGlobal analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomicsJ Lipid Res20034461071107912671038
   PubMed Web of Science ®Google Scholar
• WenkMRThe emerging field of lipidomicsNat Rev Drug Discov20054759461016052242
   PubMed Web of Science ®Google Scholar
• DennisEALipidomics joins the omics evolutionProc Natl Acad Sci U S A200910672089209019211786
   PubMed Web of Science ®Google Scholar
• FiehnOCombining genomics, metabolome analysis, and biochemical modelling to understand metabolic networksComp Funct Genomics20012315516818628911
   PubMed Web of Science ®Google Scholar
• GriffinJLAthertonHShockcorJAtzoriLMetabolomics as a tool for cardiac researchNat Rev Cardiol201181163064321931361
   PubMed Web of Science ®Google Scholar
• KishimotoKUradeROgawaTMoriyamaTNondestructive quantification of neutral lipids by thin-layer chromatography and laser-fluorescent scanning: suitable methods for “lipidome” analysisBiochem Biophys Res Commun2001281365766211237708
   PubMed Web of Science ®Google Scholar
• BrownAJLeongSLDeanRTJessupW7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaqueJ Lipid Res1997389173017459323583
   PubMed Web of Science ®Google Scholar
• ShioHHaleyNJFowlerSCharacterization of lipid-laden aortic cells from cholesterol-fed rabbits. III. Intracellular localization of cholesterol and cholesteryl esterLab Invest1979412160167459432
   PubMed Web of Science ®Google Scholar
• MallatZNakamuraTOhanJThe relationship of hydroxyei-cosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosisJ Clin Invest199910334214279927504
   PubMed Web of Science ®Google Scholar
• DegirolamoCShelnessGSRudelLLLDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fatJ Lipid Res200950SupplS434S43919029117
   PubMedGoogle Scholar
• MonacoCGreganSMNavinTJFoxwellBMDaviesAHFeldmannMToll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosisCirculation2009120242462246919948979
   PubMed Web of Science ®Google Scholar
• ColeJENavinTJCrossAJUnexpected protective role for Toll-like receptor 3 in the arterial wallProc Natl Acad Sci U S A201110862372237721220319
   PubMed Web of Science ®Google Scholar
• SeimonTANadolskiMJLiaoXAtherogenic lipids and lipo-proteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stressCell Metab201012546748221035758
   PubMed Web of Science ®Google Scholar
• HolmerSRHengstenbergCKraftHGAssociation of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarctionCirculation2003107569670112578871
   PubMed Web of Science ®Google Scholar
• MeiklePJWongGBarlowCKKingwellBALipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular diseasePharmacol Ther20141431122324509229
   PubMed Web of Science ®Google Scholar
• KontushAChantepieSChapmanMJSmall, dense HDL particles exert potent protection of atherogenic LDL against oxidative stressArterioscler Thromb Vasc Biol200323101881188812920049
   PubMed Web of Science ®Google Scholar
• Zerrad-SaadiATherondPChantepieSHDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesisArterioscler Thromb Vasc Biol200929122169217519762782
   PubMed Web of Science ®Google Scholar
• KolovouGDCokkinosDVLow serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatmentCurr Med Res Opin200218526526812240788
   PubMed Web of Science ®Google Scholar
• PhillipsMCMolecular mechanisms of cellular cholesterol effluxJ Biol Chem201428935240202402925074931
   PubMed Web of Science ®Google Scholar
• WeirJMWongGBarlowCKPlasma lipid profiling in a large population-based cohortJ Lipid Res201354102898290823868910
   PubMed Web of Science ®Google Scholar
• StübigerGAldover-MacasaetEBickerWTargeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyper-lipidemic patients using MALDI-QIT-TOF-MS/MSAtherosclerosis2012224117718622795978
   PubMed Web of Science ®Google Scholar
• HalvorsenBOtterdalKDahlTBAtherosclerotic plaque stability – what determines the fate of a plaque?Prog Cardiovasc Dis200851318319419026853
   PubMed Web of Science ®Google Scholar
• DaviesMJStability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995Circulation1996948201320208873680
   PubMed Web of Science ®Google Scholar
• FeltonCVCrookDDaviesMJOliverMFRelation of plaque lipid composition and morphology to the stability of human aortic plaquesArterioscler Thromb Vasc Biol1997177133713459261265
   PubMed Web of Science ®Google Scholar
• TabasIConsequences of cellular cholesterol accumulation: basic concepts and physiological implicationsJ Clin Invest2002110790591112370266
   PubMed Web of Science ®Google Scholar
• ChenZIchetovkinMKurtzMCholesterol in human athero-sclerotic plaque is a marker for underlying disease state and plaque vulnerabilityLipids Health Dis201096120540749
   PubMed Web of Science ®Google Scholar
• JovéMAyalaVRamírez-NúñezOLipidomic and metabolomic analyses reveal potential plasma biomarkers of early atheromatous plaque formation in hamstersCardiovasc Res201397464265223241314
   PubMed Web of Science ®Google Scholar
• HinterwirthHStübigerGLindnerWLämmerhoferMGold nanoparticle-conjugated anti-oxidized low-density lipoprotein antibodies for targeted lipidomics of oxidative stress biomarkersAnal Chem201385178376838423895666
   PubMed Web of Science ®Google Scholar
• Ramm SanderPPeerMGrandlMBogdahnUSchmitzGKalbitzerHRNMR spectroscopy of macrophages loaded with native, oxidized or enzymatically degraded lipoproteinsPLoS One201382e5636023457556
   PubMed Web of Science ®Google Scholar
• MinuzPFavaCLechiALipid peroxidation, isoprostanes and vascular damagePharmacol Rep200658Suppl576817332673
   PubMedGoogle Scholar
• StegemannCDrozdovIShalhoubJComparative lipidomics profiling of human atherosclerotic plaquesCirc Cardiovasc Genet20114323224221511877
   PubMed Web of Science ®Google Scholar
• CamontLLhommeMRachedFSmall, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalitiesArterioscler Thromb Vasc Biol201333122715272324092747
   PubMed Web of Science ®Google Scholar
• YangKChengHGrossRWHanXAutomated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomicsAnal Chem200981114356436819408941
   PubMed Web of Science ®Google Scholar
• HanXGrossRWShotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samplesMass Spectrom Rev200524336741215389848
   PubMed Web of Science ®Google Scholar
• QuehenbergerOArmandoAMBrownAHLipidomics reveals a remarkable diversity of lipids in human plasmaJ Lipid Res201051113299330520671299
   PubMed Web of Science ®Google Scholar
• DennisEADeemsRAHarkewiczRA mouse macrophage lipidomeJ Biol Chem201028551399763998520923771
   PubMed Web of Science ®Google Scholar
• MeiklePJWongGTsorotesDPlasma lipidomic analysis of stable and unstable coronary artery diseaseArterioscler Thromb Vasc Biol201131112723273221903946
   PubMed Web of Science ®Google Scholar
• WenkMRLipidomics: new tools and applicationsCell2010143688889521145456
   PubMed Web of Science ®Google Scholar
• The nomenclature of lipidsRecommendations (1976) IUPAC-IUB Commission on Biochemical NomenclatureLipids1977126455468881947
   PubMed Web of Science ®Google Scholar
• RasmienaAANgTWMeiklePJMetabolomics and ischaemic heart diseaseClin Sci (Lond)2013124528930623157406
   PubMed Web of Science ®Google Scholar
• SoininenPKangasAJWürtzPHigh-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolismAnalyst200913491781178519684899
   PubMed Web of Science ®Google Scholar
• WiesnerPLeidlKBoettcherASchmitzGLiebischGLipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometryJ Lipid Res200950357458518832345
   PubMed Web of Science ®Google Scholar
• IsobeYAritaMMatsuedaSIdentification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acidJ Biol Chem201228713105251053422275352
   PubMed Web of Science ®Google Scholar
• BlanksbySJMitchellTWAdvances in mass spectrometry for lipidomicsAnnu Rev Anal Chem (Palo Alto Calif)2010343346520636050
   PubMed Web of Science ®Google Scholar
• EjsingCSDuchoslavESampaioJAutomated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanningAnal Chem200678176202621416944903
   PubMed Web of Science ®Google Scholar
• EjsingCSSampaioJLSurendranathVGlobal analysis of the yeast lipidome by quantitative shotgun mass spectrometryProc Natl Acad Sci U S A200910672136214119174513
   PubMed Web of Science ®Google Scholar
• AlmeidaRPaulingJKSokolEHannibal-BachHKEjsingCSComprehensive lipidome analysis by shotgun lipidomics on a hybrid quadrupole-orbitrap-linear ion trap mass spectrometerJ Am Soc Mass Spectrom201526113314825391725
   PubMed Web of Science ®Google Scholar
• Di GirolamoFLanteIMuracaMPutignaniLThe role of mass spectrometry in the “omics” eraCurr Org Chem201317232891290524376367
   PubMed Web of Science ®Google Scholar
• FengXLiuXLuoQLiuBFMass spectrometry in systems biology: an overviewMass Spectrom Rev200827663566018636545
   PubMed Web of Science ®Google Scholar
• HanXYangKGrossRWMulti-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analysesMass Spectrom Rev201231113417821755525
   PubMed Web of Science ®Google Scholar
• FennJBMannMMengCKWongSFWhitehouseCMElectrospray ionization for mass spectrometry of large biomoleculesScience1989246492664712675315
   PubMed Web of Science ®Google Scholar
• GriffithsRLSarsbyJGuggenheimEJFormal lithium fixation improves direct analysis of lipids in tissue by mass spectrometryAnal Chem201385157146715323879734
   PubMed Web of Science ®Google Scholar
• LonguespéeRBoyonCDesmonsASpectroimmunohistochemistry: a novel form of MALDI mass spectrometry imaging coupled to immunohistochemistry for tracking antibodiesOMICS201418213214124351082
   PubMed Web of Science ®Google Scholar
• GawrischKEldhoNVPolozovIVNovel NMR tools to study structure and dynamics of biomembranesChem Phys Lipids20021161–213515112093539
   PubMed Web of Science ®Google Scholar
• HornPJChapmanKDLipidomics in situ: insights into plant lipid metabolism from high resolution spatial maps of metabolitesProg Lipid Res201454325224480404
   PubMed Web of Science ®Google Scholar
• SezginESchwillePFluorescence techniques to study lipid dynamicsCold Spring Harb Perspect Biol2011311a00980321669985
   PubMed Web of Science ®Google Scholar
• GaoXZhangQMengDA reversed-phase capillary ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) method for comprehensive top-down/bottom-up lipid profilingAnal Bioanal Chem201240292923293322354571
   PubMed Web of Science ®Google Scholar
• SandraKSandraPLipidomics from an analytical perspectiveCurr Opin Chem Biol201317584785323830914
   PubMed Web of Science ®Google Scholar
• LiJRomestaingCHanXCardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesityCell Metab201012215416520674860
   PubMed Web of Science ®Google Scholar
• ChanRUchilPDJinJRetroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositidesJ Virol20088222112281123818799574
   PubMed Web of Science ®Google Scholar
• BrunelleALaprévoteOLipid imaging with cluster time-of-flight secondary ion mass spectrometryAnal Bioanal Chem20093931313518777109
   PubMed Web of Science ®Google Scholar
• KolovouGDKaterinaAIoannisVCokkinosDVSimvastatin: two decades in a circleCardiovasc Ther200826216617818485137
   PubMed Web of Science ®Google Scholar
• LaaksonenRJänisMTOresicMLipidomics-based safety biomarkers for lipid-lowering treatmentsAngiology2008592 Suppl65S68S18632766
   PubMedGoogle Scholar
• ChenFMaridakisVO’NeillEAThe effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemiaBiomarkers201116432133321417623
   PubMed Web of Science ®Google Scholar
• Kaddurah-DaoukRBaillieRAZhuHLipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics StudyMetabolomics20106219120120445760
   PubMed Web of Science ®Google Scholar
• YetukuriLHuopaniemiIKoivuniemiAHigh density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudyPLoS One201168e2358921887280
   PubMed Web of Science ®Google Scholar
• AertsJMOttenhoffRPowlsonASPharmacological inhibition of glucosylceramide synthase enhances insulin sensitivityDiabetes20075651341134917287460
   PubMed Web of Science ®Google Scholar
• HollandWLBrozinickJTWangLPInhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistanceCell Metab20075316717917339025
   PubMed Web of Science ®Google Scholar
• ZhaoHPrzybylskaMWuIHInhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetesDiabetes20075651210121817470562
   PubMed Web of Science ®Google Scholar
• BijlNSokolovićMVrinsCModulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in miceHepatology20095051431144119731235
   PubMed Web of Science ®Google Scholar
• DidangelosAStegemannCMayrMThe -omics era: proteomics and lipidomics in vascular researchAtherosclerosis20122211121722024275
   PubMed Web of Science ®Google Scholar
• EkroosKJänisMTarasovKHurmeRLaaksonenRLipidomics: a tool for studies of atherosclerosisCurr Atheroscler Rep201012427328120425241
   PubMed Web of Science ®Google Scholar
• AritaMMediator lipidomics in acute inflammation and resolutionJ Biochem2012152431331922923733
   PubMed Web of Science ®Google Scholar
• LamSMShuiGLipidomics as a principal tool for advancing biomedical researchJ Genet Genomics201340837539023969247
   PubMed Web of Science ®Google Scholar
• Bou KhalilMHouWZhouHLipidomics era: accomplishments and challengesMass Spectrom Rev201029687792920931646
   PubMed Web of Science ®Google Scholar
• FeigJEFeigJLKiniASStatins, atherosclerosis regression and HDL: Insights from within the plaqueInt J Cardiol201518916817125897898
   PubMed Web of Science ®Google Scholar
• NichollsSJBorgmanMNissenSEImpact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN)Curr Med Res Opin20112761119112921446892
   PubMed Web of Science ®Google Scholar
• PuriRLibbyPNissenSELong-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURNEur Heart J Cardiovasc Imaging201415438038824448227
   PubMed Web of Science ®Google Scholar
• AlbertMAGlynnRJFonsecaFARace, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trialAm Heart J20111621106114.e221742096
   PubMed Web of Science ®Google Scholar
• BergheanuSCReijmersTZwindermanAHLipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statinsCurr Med Res Opin20082492477248718655752
   PubMed Web of Science ®Google Scholar
• SmithEBIntimal and medial lipids in human aortasLancet19601712879980313831944
   PubMedGoogle Scholar
• SchisselSLJiangXTweedie-HardmanJSecretory sphingomy-elinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion developmentJ Biol Chem19982735273827469446580
   PubMed Web of Science ®Google Scholar
• NoëlCMarcelYLDavignonJPlasma phospholipids in the different types of primary hyperlipoproteinemiaJ Lab Clin Med19727946116215021301
   PubMed Web of Science ®Google Scholar
• JeongTsSchisselSLTabasIPownallHJTallARJiangXIncreased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinaseJ Clin Invest199810149059129466986
   PubMed Web of Science ®Google Scholar
• KolovouGAnagnostopoulouKMikhailidisDPCokkinosDVApolipoprotein E knockout modelsCurr Pharm Des200814433835118289060
   PubMed Web of Science ®Google Scholar
• ParkTSPanekRLRekhterMDModulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout miceAtherosclerosis2006189226427216458317
   PubMed Web of Science ®Google Scholar
• OestvangJBonnefont-RousselotDNinioEHakalaJKJohansenBAnthonsenMWModification of LDL with human secretory phospholipase A(2) or sphingomyelinase promotes its arachidonic acid-releasing propensityJ Lipid Res200445583183814754906
   PubMed Web of Science ®Google Scholar
• VorosSMaurovich-HorvatPMarvastyIBPrecision phenotyping, panomics, and system-level bioinformatics to delineate complex biologies of atherosclerosis: rationale and design of the “Genetic Loci and the Burden of Atherosclerotic Lesions” studyJ Cardiovasc Comput Tomogr20148644245125439791
   PubMed Web of Science ®Google Scholar